newsfilter
← Latest News
GlobeNewswire·

Oncternal Therapeutics Announces the Appointment of Jill DeSimone to the Board of Directors

SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (NASDAQ:ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the